Vesper Medical, Inc.

Vesper Medical, Inc. is a Health Care startup founded in 2016 and based in the United States. The company's slogan "Advancing and improving the treatment of deep venous disease" reflects its focus on innovation in treating this medical condition. Vesper Medical has attracted significant funding, with the last investment being a notable $37.00M Venture Round secured on 29 May 2019. The investors in this round included New Enterprise Associates, Gilde Healthcare, Vensana Capital, and Quaker Partners, showcasing the strong support and belief in the company's mission. The company's main offering is the Vesper DUO Venous Stent System, a next-generation, modular, and uniquely engineered venous stent portfolio designed to address the anatomical challenges related to the iliac and femoral veins. This system provides the capability to customize therapy to a broad range of patient needs, indicating a potential for substantial impact in the field of treating deep venous disease. Vesper Medical's innovative approach and the support it has garnered from reputable investors position it as a promising player in the health care industry.